- Home
- SRZN vs MNDO Comparison
SRZN vs MNDO Comparison
Compare SRZN & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- MNDO
- Stock Information
- Founded
- SRZN 2015
- MNDO 1995
- Country
- SRZN United States
- MNDO Israel
- Employees
- SRZN N/A
- MNDO 144
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- MNDO EDP Services
- Sector
- SRZN Health Care
- MNDO Technology
- Exchange
- SRZN Nasdaq
- MNDO Nasdaq
- Market Cap
- SRZN 38.1M
- MNDO 39.7M
- IPO Year
- SRZN N/A
- MNDO 2000
- Fundamental
- Price
- SRZN $8.99
- MNDO $1.96
- Analyst Decision
- SRZN
- MNDO
- Analyst Count
- SRZN 0
- MNDO 0
- Target Price
- SRZN N/A
- MNDO N/A
- AVG Volume (30 Days)
- SRZN 33.9K
- MNDO 24.5K
- Earning Date
- SRZN 11-06-2024
- MNDO 11-05-2024
- Dividend Yield
- SRZN N/A
- MNDO 12.28%
- EPS Growth
- SRZN N/A
- MNDO N/A
- EPS
- SRZN N/A
- MNDO 0.23
- Revenue
- SRZN $10,000,000.00
- MNDO $21,856,000.00
- Revenue This Year
- SRZN N/A
- MNDO N/A
- Revenue Next Year
- SRZN N/A
- MNDO N/A
- P/E Ratio
- SRZN N/A
- MNDO $8.50
- Revenue Growth
- SRZN N/A
- MNDO 2.27
- 52 Week Low
- SRZN $6.00
- MNDO $1.70
- 52 Week High
- SRZN $16.19
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- SRZN 45.92
- MNDO 47.28
- Support Level
- SRZN $8.10
- MNDO $1.94
- Resistance Level
- SRZN $10.76
- MNDO $2.00
- Average True Range (ATR)
- SRZN 1.25
- MNDO 0.03
- MACD
- SRZN -0.16
- MNDO -0.00
- Stochastic Oscillator
- SRZN 22.90
- MNDO 50.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.